TY - JOUR
T1 - Suppressive oligodeoxynucleotides protect mice from lethal endotoxic shock
AU - Shirota, Hidekazu
AU - Gursel, Ihsan
AU - Gursel, Mayda
AU - Klinman, Dennis M.
N1 - Copyright:
Copyright 2017 Elsevier B.V., All rights reserved.
PY - 2005/4/15
Y1 - 2005/4/15
N2 - Endotoxic shock is a life-threatening condition caused by exposure to bacterial LPS. LPS triggers the release of acute phase, proinflammatory, and Th1 cytokines that facilitate the development of endotoxic shock. Synthetic oligodeoxynucleotides (ODN) expressing suppressive TTAGGG motifs effectively down-regulate the production of proinflammatory and Th1 cytokines elicited by a variety of immune stimuli. The current results demonstrate that suppressive ODN protect mice from LPS-induced endotoxic shock. Underlying this protective effect is the ability of suppressive ODN to bind to and prevent the phosphorylation of STAT1 and STAT4, thereby blocking the signaling cascade mediated by LPS-induced IFN-β and IL-12. These findings suggest that suppressive ODN might be of use in the treatment of endotoxic shock.
AB - Endotoxic shock is a life-threatening condition caused by exposure to bacterial LPS. LPS triggers the release of acute phase, proinflammatory, and Th1 cytokines that facilitate the development of endotoxic shock. Synthetic oligodeoxynucleotides (ODN) expressing suppressive TTAGGG motifs effectively down-regulate the production of proinflammatory and Th1 cytokines elicited by a variety of immune stimuli. The current results demonstrate that suppressive ODN protect mice from LPS-induced endotoxic shock. Underlying this protective effect is the ability of suppressive ODN to bind to and prevent the phosphorylation of STAT1 and STAT4, thereby blocking the signaling cascade mediated by LPS-induced IFN-β and IL-12. These findings suggest that suppressive ODN might be of use in the treatment of endotoxic shock.
UR - http://www.scopus.com/inward/record.url?scp=17044423406&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=17044423406&partnerID=8YFLogxK
U2 - 10.4049/jimmunol.174.8.4579
DO - 10.4049/jimmunol.174.8.4579
M3 - Article
C2 - 15814679
AN - SCOPUS:17044423406
SN - 0022-1767
VL - 174
SP - 4579
EP - 4583
JO - Journal of Immunology
JF - Journal of Immunology
IS - 8
ER -